Britain’s biotech firms now have a code of conduct designed to prevent them
from overhyping the progress of experimental drugs. Published this week by the
BioIndustry Association (BIA), the code was drafted in the wake of a damaging
scandal last year
(This Week, 4 July 1998, p 20).
From now on, companies must
have their scientific and clinical progress audited by external experts. Failure
to comply could mean expulsion from the BIA.
More from 快猫短视频
Explore the latest news, articles and features
Popular articles
Trending 快猫短视频 articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Does gravity create reality? A shocking path to a theory of everything
4
Glaciers in the 'roof of the world' have suddenly started melting
5
Photons behave very strangely if you try to cut them
6
Why your brain needs plenty of 鈥淎ha!鈥 moments
7
How a radical new view of life could reveal its origin 鈥 and aliens
8
Aim high but don't shoot for the moon, mathematicians advise
9
Embryos made without sperm or eggs reveal why many pregnancies fail
10
Q-Day could destroy bitcoin 鈥 and our retirement savings
